Percentage of Hemoglobin A1C(HbA1c) as an Indicator of Pre-Diabetic Condition in Impaired Glucose Level Patients
American Journal of Internal Medicine
Volume 2, Issue 4, July 2014, Pages: 59-62
Received: Jun. 16, 2014; Accepted: Jun. 28, 2014; Published: Jun. 30, 2014
Views 6261      Downloads 173
Authors
Binay Kumar Raut, Department of Biochemistry, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal
Mukesh Kumar Jha, Department of Physiology, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal
Sapana Koju, Faculty of Human Biology, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal
Kishor Khanal, Department of Community Medicine, Kathmandu University School of Medical Sciences, Kavre, Nepal
Shyam Sundar Malla, Department of Biochemistry, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal
Article Tools
Follow on us
Abstract
Background: The high prevalence of diabetes mellitus has emerged as a worldwide public health problem in the past 20 years. Type 2 diabetes is the most common form of diabetes, estimated to account for 85–90% of diabetes. Hemoglobin A(1c) (HbA1c) has been widely used as a clinically important assessment tool for outcome analyses related to glycemic control. The HbA1c test has been shown to predict the risk for the development of many of the chronic complications in diabetes. Objectives: The study was undertaken to find out if HbA1c levels can be used as indicator of the pre-diabetic condition in patients with impaired blood sugar levels around Kathmandu valley and to find out the percentage of HbA1c in those patients. Also a correlation analysis with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) levels was carried out. Methods: The study was conducted in the Department of Biochemistry, Kathmandu University School of Medical Sciences. A total of 102 patients with impaired blood glucose levels participated in the study. Estimation of HbA1c was performed by using a commercial NycoCard Kit, a rapid in vitro test for the measurement of glycated hemoglobin in human blood. Results: The mean % of HbA1c was found to be 6.44902 amongst the 102 patients and no correlation was found to be observed between HbA1c with IFG and IGT values. Conclusion: In conclusion HbA1c % proved to be a valuable indicator of the pre-diabetic condition and could contribute to understanding the role of the various risk factors of dietary, social and physical nature in the development of diabetes.
Keywords
Diabetes Mellitus, HbA1C, Impaired Fasting Glucose (IFG)
To cite this article
Binay Kumar Raut, Mukesh Kumar Jha, Sapana Koju, Kishor Khanal, Shyam Sundar Malla, Percentage of Hemoglobin A1C(HbA1c) as an Indicator of Pre-Diabetic Condition in Impaired Glucose Level Patients, American Journal of Internal Medicine. Vol. 2, No. 4, 2014, pp. 59-62. doi: 10.11648/j.ajim.20140204.11
References
[1]
Nair.M, Prabhakaram.D, Venkat Narayan K.M, Sinha.R, Lakshmy.R. et.al. HbA1c Values for Defining Diabetes and Impaired Fasting Glucose in Asian Indians.Prim Care Diabetes.2011. 5(2):95-102.
[2]
Kaznowska-Bystryk. I, Goryriska. A, Solski. J. Evaluation of metabolic control in patients with type 2 diabetes. WiadLek. 2011.64(3):170-5.
[3]
Wael.E, James. V. Value of Hemoglobin A1c in Diagnosing Diabetes Mellitus within a Chronic Disease Management System Illustrated by the Receiver operating Characteristic curve. Endocrine Practice.2009. 16:14-20.
[4]
Zhang.H.Y,Ma.J.W,Thomas.N.G, Xu.J.Y, Lao.Q.X, Ku.J.X.et.al. Diabetes and Pre-diabetes as Determined by GlycatedHaemoglobin A1C and Glusoce Levels in a Developing Southern Chinese Population. PLoSOne.2012.7 (5): e37260.
[5]
Cozma.I.A, Sievenpiper.L.J, de Souza.J.R, Chiavaroli.L, Ha.V, Wang.D et.al. Effects of Fructose on Glycemic Control in Diabetes. Diabetes Care. 35 no. 7. 2012.1611-20.
[6]
Hoshino.J, Mol-nar.Z.M.Yamagata.K,Ubara.Y,Takaichi.K,Kovesdy.P.C,et.al. Developing an HbA1c-Based Equation toEstimate Blood Glucose in Maintenance Hemodialysis Patients. care.diabetesjournals.org. 2012.
[7]
Bacha.F,Pyle.L,Nadeau.K.Cuttler L, Goland R, Haymond M, et.al. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study.Pediatric Di-abetes. 2012.13(5).376-83
[8]
Lee.M.J, Gebremarjam.A, Wu.L.E, LaRose.J, Gur-ney.G.J.Evaluation of nonfasting tests to screen for childhood and Adolescent Dysglyce-mia.Diabetes Care. 2011.34(12). 2597-602.
[9]
Stene.C.L,Barriga.K,Hoffman.M.et.al. Normal but increasing hemoglobin A1C levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatric Di-abetes.2006.7(5).243-7
[10]
Emden.M.C, Shaw.E.J, Colman.P.J, Colagiuri.S,Twigg.S.M, Graham R D Jones.G.RD., Goodall.I.et.al. The role of HbA1c in the diagnosis of diabetes mellitus in Australia. The medical journal of Australia.2012.197 (4). 220-1
[11]
Pokharel.DR,Gautam.N, Archana.J, Nagamma.T, Kumar.R, Sapkota.RM,Frequency of Type 2 Diabetes mellitus and Impaired Glycemia in a Teaching Hospital of South-Western Nepal .Asian Journal of Medical Sciences 2011 (2).202-206
[12]
Bunn .H.F, Evaluation of Glycosylated Hemoglobin in Diabetic Patients. Diabetes 1981(30).
[13]
Selvin.E, Steffes. M.W, Zhu. H, Matsushita.K, wagenknecht.L, Pankow.J, Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults. N Engl J Med2010; 362(9): 800–811.
[14]
C. M. Bennett.C.M, Guo.M, Dharmage.S.C, HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review. Diabetic medicine 2007; 24: 333-343.
[15]
E. Adeghate, P.Schattner, E. Dunn, an Update on the Etiology and Epidemiology of Diabetes Mellitus. Annals of the New York Academy of Sciences2006; 1084: 1–29. doi: 10.1196/annals.1372.029.
[16]
Mokdaa.A.H, Ford.E.S, Bowman.B.A, Nelson.D.E, Engel-gau.M.M, Vinicor.F, Diabetes Trends in the U.S.: 1990–1998. Diabetes care 2000; 23.
[17]
Rao.S.S, disraeli.P, Mcgregor.T, Impaired Glucose Tolerance and Impaired fasting Glu-cose. Am Fam Physician. 2004 Apr 15; 69(8):1961-1968.
[18]
Goldstein. D.E, Little.R.R, Lo-renz.R.A, Malone.J.I, Nathan.D, Peterson.C.M, Tests of glycemia in diabetes. Diabetes care 1995; 18:896-909.
[19]
Selvin.E, Crainiceanu.C.M, Brancati.F.L, Coresh.J, Short-term Variability in Measures of Glycemia and Implications for the Classification of Diabetes FREE .Arch Intern Med. 2007;167(14):1545-1551.
[20]
Ono.K, Limbu.Y.U, Rai.S.K, Kurokawa.M, Yanagida.J, Rai.G, et.al. The prevalence of type 2 diabetes mellitus and inpaired fasting glucose in semi-urban population of Nepal. Nepal Med coll J 2007; 9(3):154-6.
[21]
McCarter.R.J, hempe.J.M, Chalew.S.A, Mean Blood Glucose and Biological Variation Have Greater Influence on HbA1c Levels than Glucose In-stability. Diabetes Carecare 2006; 29 (2): 352-355.
[22]
Bonora E, Tuomilehto J.The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011 May;34 Suppl 2:S184-90. doi: 10.2337/dc11-s216.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186